RMB Corvest and Brunel in growth partnership

Private equity deal broadens Brunel’s BEE standing while extending RMB Corvest’s portfolio in the fast-growing healthcare sector.

A private equity consortium comprising RMB Corvest and Umoya Capital Partners has, alongside Calibre Capital, invested in Brunel Laboratoria (Pty) Ltd.

MoneywebNOW’s Simon Brown chats with RMB Corvest executive Geoff Wilmot, Umoya Capital Partners partner Sabelo Sithebe-Marishane and Brunel CEO Paul Jonker about the partnership in more detail.

Brought to you by RMB Corvest. 

Moneyweb does not endorse any product or service being advertised in sponsored articles on our platform.

AUTHOR PROFILE

COMMENTS   0

Comments on this article are closed.

LATEST CURRENCIES  

USD / ZAR
GBP / ZAR
EUR / ZAR
BTC / USD

Instrument Details  

You do not have any portfolios, please create one here.
You do not have an alert portfolio, please create one here.
INSIDER SUBSCRIPTION APP VIDEOS RADIO / LISTEN LIVE SHOP OFFERS WEBINARS NEWSLETTERS TRENDING

Follow us: